Advinus Therapeutics Limited, a research-based pharmaceutical company, provides drug discovery, and pharmaceutical and agrochemical development services in India. The company’s drug discovery services include developing small molecule therapies for indications in metabolic diseases, such as diabetes and obesity; inflammatory diseases, including chronic obstructive pulmonary diseases, inflammatory bowel diseases, and autoimmune disorders; pain/degenerative diseases, which comprise Parkinson’s diseases; and neglected diseases, such as leishmaniasis, dengue fever, tuberculosis, leprosy, and malaria. Its pharmaceutical development services include process development and synthesis, process chemi...
21 & 22 Phase II
Peenya Industrial Area
Bengaluru, 560 058
Founded in 2005
Advinus Therapeutics Limited Reports Unaudited Earnings Results for the Year Ended March 31, 2014
May 31 14
Advinus Therapeutics Limited reported unaudited earnings results for the year ended March 31, 2014. For the period, the company reported revenue was INR 1,544,976,958 against INR 1,290,716,834 a year ago. Earnings before interest, tax, depreciation and amortization was INR 114,844,726 against INR 133,691,107 a year ago. Loss before tax was INR 367,775,831 against INR 317,501,464 a year ago. Loss after tax was INR 367,775,831 against INR 317,501,464 a year ago. Loss per share was INR 2.75 against INR 2.38 a year ago. Net cash generated from operating activities was INR 248,516,688 against INR 22,841,186 a year ago. Capital expenditure on fixed assets, including capital advance was INR 80,621,764 against INR 26,436,734 a year ago.
Advinus Therapeutics Limited Reports Earnings Results for the Six Months Ended September 30, 2013
Nov 16 13
Advinus Therapeutics Limited reported earnings results for the six months ended September 30, 2013. For the period, the company reported net income from sales and services was INR 660.924 million against INR 371.129 million a year ago. Profit from operations was INR 37.858 million against loss of INR 229.229 million a year ago. Net loss was INR 89.297 million against INR 368.884 million a year ago. Loss per share was INR 0.67 against INR 2.76 a year ago.
Advinus Therapeutics Limited, Board Meeting, Oct 17, 2013
Nov 16 13
Advinus Therapeutics Limited, Board Meeting, Oct 17, 2013. Agenda: To consider unaudited earnings results for the six months ended September 30, 2013.